Production (Stage)
MedX Health Corp
MDX.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.01% | -39.48% | -33.74% | 2.03% | -12.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.01% | -39.48% | -33.74% | 2.03% | -12.81% |
| Cost of Revenue | 7.66% | -18.10% | -25.24% | 21.71% | -1.87% |
| Gross Profit | 1.44% | -60.19% | -43.47% | -18.52% | -24.92% |
| SG&A Expenses | -30.25% | -30.70% | -18.48% | -21.35% | -21.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.90% | -25.86% | -17.40% | -17.04% | -23.21% |
| Operating Income | 24.81% | 23.43% | 14.64% | 19.63% | 24.58% |
| Income Before Tax | 21.63% | 41.78% | 26.98% | 18.27% | 13.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 21.63% | 41.78% | 26.98% | 18.27% | 13.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.63% | 41.78% | 26.98% | 18.27% | 13.84% |
| EBIT | 24.81% | 23.43% | 14.64% | 19.63% | 24.58% |
| EBITDA | 24.62% | 23.95% | 14.41% | 19.50% | 24.79% |
| EPS Basic | 44.13% | 58.33% | 41.04% | 27.23% | 17.13% |
| Normalized Basic EPS | 50.00% | 49.63% | 31.82% | 18.05% | 8.15% |
| EPS Diluted | 44.13% | 58.33% | 41.04% | 27.23% | 17.13% |
| Normalized Diluted EPS | 50.00% | 49.63% | 31.82% | 18.05% | 8.15% |
| Average Basic Shares Outstanding | 35.22% | 39.04% | 28.78% | 17.91% | 7.27% |
| Average Diluted Shares Outstanding | 35.22% | 39.04% | 28.78% | 17.91% | 7.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |